Ocugen Inc. (OCGN) stock plunged -8.85% to $2.37 in the pre-market trading after reporting the appointment of a vaccine scientific advisory board comprised of leading
Ocugen Inc. (OCGN) stock soared 77.6% to $1.43 in the pre-market trading after signing a binding letter of intent (LOI) with Bharat Biotech to develop
As California reinforced its pandemic shutdown during Christmas and COVID-19 cases rose in the United States and Europe on Tuesday, counteracting hope emerging about vaccine
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.